Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
about
Recent advances in understanding apicomplexan parasitesThe gut mucosal immune response to Toxoplasma gondiiPersistence of Toxoplasma gondii in the central nervous system: a fine-tuned balance between the parasite, the brain and the immune systemNeurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondiiIFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic AcidStructure of the Toxoplasma gondii ROP18 Kinase Domain Reveals a Second Ligand Binding Pocket Required for Acute VirulenceLong-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic InfectionsEvolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune CellsInterferon-induced guanylate-binding proteins in inflammasome activation and host defenseSTAT1 Signaling in Astrocytes Is Essential for Control of Infection in the Central Nervous System.The E2-like conjugation enzyme Atg3 promotes binding of IRG and Gbp proteins to Chlamydia- and Toxoplasma-containing vacuoles and host resistance.The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice.The Toxoplasma pseudokinase ROP5 is an allosteric inhibitor of the immunity-related GTPases.Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS.Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases.Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii.Differential induction of TLR3-dependent innate immune signaling by closely related parasite species.Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.Identification of a putative quantitative trait nucleotide in guanylate binding protein 5 for host response to PRRS virus infection.Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection.Transcriptional and Linkage Analyses Identify Loci that Mediate the Differential Macrophage Response to Inflammatory Stimuli and Infection.RabGDIα is a negative regulator of interferon-γ-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondiiCoexpression Network Analysis of Benign and Malignant Phenotypes of SIV-Infected Sooty Mangabey and Rhesus Macaque.A Noncanonical Autophagy Pathway Restricts Toxoplasma gondii Growth in a Strain-Specific Manner in IFN-γ-Activated Human Cells.Guanylate binding proteins directly attack Toxoplasma gondii via supramolecular complexes.Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection.Enrichment of IFN-γ producing cells in different murine adipose tissue depots upon infection with an apicomplexan parasiteA newly discovered member of the Atlastin family, BmAtlastin-n, has an antiviral effect against BmNPV in Bombyx moriSecretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.Irgm1-deficient mice exhibit Paneth cell abnormalities and increased susceptibility to acute intestinal inflammation.Toxoplasma gondii Inhibits gamma interferon (IFN-γ)- and IFN-β-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA.Administration of a maple syrup extract to mitigate their hepatic inflammation induced by a high-fat diet: a transcriptome analysis.Interferon-inducible GTPases in cell autonomous and innate immunity.Immune Response: Intracellular pathogens under attackToxoplasma Effectors Targeting Host Signaling and Transcription.Interferon-Inducible GTPases in Host Resistance, Inflammation and Disease.Francisella Inflammasomes: Integrated Responses to a Cytosolic Stealth Bacterium.Brains and Brawn: Toxoplasma Infections of the Central Nervous System and Skeletal Muscle.Protective and Pathological Immunity during Central Nervous System Infections.Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system.
P2860
Q26747055-18FFAF6A-3E0A-4E16-A2A6-5E6DF4F63809Q26863747-BD1B1A75-1403-491A-8D9F-ADABFAC0A7CFQ27026477-9EF09DAB-BE08-43C9-AADA-535A8B6F28E8Q27315747-43404DA2-1BC3-4C76-802E-4F57DCB3FA95Q27316130-58A9B7B4-5D25-48E6-B9FA-7CC9258FF667Q27680375-14222FCB-D83D-4FD0-BE5E-326B31CF1C3FQ28082315-F3C87150-DF7D-425A-84F5-EEE8E8840A54Q28559840-47AD0A00-11C6-445C-8601-CAF933D62343Q28595838-52DBB0C9-CEB1-4A47-8A8F-ABB2EC04A59BQ30275440-EE1BF8AB-7B37-4476-90CC-98283FD4E249Q31148891-6D4B675C-03ED-40D8-B00C-3FB93B1C0BDAQ33861156-474D8A88-9F8B-491B-B623-0EC6AE7D8DD0Q34283543-3FA1F3B8-97E1-4368-A5EC-B663B16ED1B1Q34414371-9B54F013-5863-4A08-8CB5-BECC9EB43C0AQ34415551-E0BA3A14-CECA-488E-9ADE-F9535A496192Q34697891-B623426E-1B04-4154-AF1F-0409EA5F5332Q35088720-BC45ED0D-247E-46F6-BCFA-C4364B06A226Q35172341-441370F5-EEFA-4367-8C3F-C26DCA48DD9EQ35643308-904F5F15-35EB-434D-B481-79EB2B11C333Q35756352-BF5BA554-79CB-4DF8-92B8-1806E0647B49Q35824601-333A0645-BEF5-4B6D-A795-A78014A3D7E6Q35989946-7221FB3C-EEBE-4606-8B2C-CB8E7BC3F20CQ36046669-BA6648B2-E3CF-4757-B2F2-E760D9BCCA89Q36143601-F13518FC-F95B-4610-B614-45E298A20650Q36673756-20623A0C-B775-4821-BE6D-E8FB42779290Q36694053-CD455114-DD13-4A6A-90E3-F9C787E16EB5Q36713490-8AAC07BE-0C5C-4BE5-B2A6-3E1C4B930333Q37049741-A796655B-B58E-44AF-AB14-294E133B778DQ37119146-1071E0FF-4432-465E-A420-88FB4FD2DC0DQ37234762-B38E3FA9-624D-4F74-AB4E-4E2DD1B0E2A1Q37546374-FA293554-49A6-4C6E-8747-B04ACCF34E0CQ38463020-F521F5D4-B4EB-41A4-A02D-E160A8C6FE73Q38634433-C5A6E988-8BB1-4BA8-B3AF-E777E40E526EQ38653442-E6C6C830-1F86-49CA-AC15-DDA5C037877CQ38731005-6FA41273-0CE3-46A5-8073-3FDAFCF9C877Q38834935-F7E4E150-8665-4F2A-950A-565047E88A4FQ38909303-F43BDED8-F724-4981-814C-77459CC8F039Q39291870-B39FAC17-55B3-40BB-987C-5D15194C31EFQ39388323-7CAB2CDD-75A1-4735-B8B8-03CF11DBD3D0Q39447825-28E43613-552D-4B12-AC33-E9E0CC113C4F
P2860
Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
@ast
Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
@en
type
label
Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
@ast
Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
@en
prefLabel
Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
@ast
Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
@en
P2093
P2860
P356
P1476
Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication
@en
P2093
Carolin Konermann
Cornelia Beuter-Gunia
Daniel Degrandi
Elisabeth Kravets
Eva Wischmann
Sandra Beer-Hammer
Sarah Lahme
Verena Klümpers
P2860
P304
P356
10.1073/PNAS.1205635110
P407
P577
2012-12-17T00:00:00Z